T. Rowe Price Associates »

Karyopharm Therapeutics shares owned by T. Rowe Price Associates

Quarter-by-quarter ownership of Karyopharm Therapeutics (KPTI) shares owned by T. Rowe Price Associates from 13F filings

Historical chart of T. Rowe Price Associates investment in Karyopharm Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Karyopharm Therapeutics held by T. Rowe Price Associates consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Karyopharm Therapeutics by T. Rowe Price Associates

Quarter filed Position value Share count Share price at filing
2026-03-31 $61k 11k 5.60
2025-12-31 $81k 11k 7.44
2025-09-30 $72k 11k 6.61
2025-06-30 $47k 11k 4.32